StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.01−0.01 (-0.50%)

Close on Nov 17, 2026Market cap $14.81MP/E –Yield –

GeoVax Labs price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

GeoVax Labs's price to book ratio was 9.0× on Nov 11, 2026, against 62.2× a year earlier. Over the last 5 years it ranged from 1.4× to 411.6×, with a median of 84.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.0×−16.8
2025Dec 31, 202525.9×−262.3
2024Apr 30, 2024288.2×−79.1
2023Apr 28, 2023367.2×+266.9
2017Oct 31, 2017100.4×−25.3
2016Dec 30, 2016125.7×+104.3
2015Dec 31, 201521.4×−104.4
2014Nov 28, 2014125.8×+0.0
2013Dec 31, 2013125.8×−3.2
2012Dec 31, 2012129.1×−93.3
2011Dec 30, 2011222.4×+137.7
2010Dec 31, 201084.7×–

More GeoVax Labs figures

See a number that looks wrong?